Special Issue “Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy”
Funding
Conflicts of Interest
References
- Koenig, M.; Hoffman, E.P.; Bertelson, C.J.; Monaco, A.P.; Feener, C.; Kunkel, L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50, 509–517. [Google Scholar] [CrossRef]
- Abreu, N.J.; Waldrop, M.A. Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy. Pediatr. Pulmonol. 2020. [Google Scholar] [CrossRef] [PubMed]
- Knyazeva, A.; Khudiakov, A.; Vaz, R.; Muravyev, A.; Sukhareva, K.; Sejersen, T.; Kostareva, A. FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling. Genes 2020, 11, 1343. [Google Scholar] [CrossRef]
- Jorholt, J.; Formicheva, Y.; Vershinina, T.; Kiselev, A.; Muravyev, A.; Demchenko, E.; Fedotov, P.; Zlotina, A.; Rygkov, A.; Vasichkina, E.; et al. Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with ALPK3 Homozygous and Compound Heterozygous Variants. Genes 2020, 11, 1201. [Google Scholar] [CrossRef]
- Ignatieva, E.V.; Ivanova, O.A.; Komarova, M.Y.; Khromova, N.V.; Polev, D.E.; Kostareva, A.A.; Sergushichev, A.; Dmitrieva, R.I. LMNA Mutations G232E and R482L Cause Dysregulation of Skeletal Muscle Differentiation, Bioenergetics, and Metabolic Gene Expression Profile. Genes 2020, 11, 1057. [Google Scholar] [CrossRef]
- Alcántara-Ortigoza, M.A.; Reyna-Fabián, M.E.; González-del Angel, A.; Estandia-Ortega, B.; Bermúdez-López, C.; Cruz-Miranda, G.M.; Ruíz-García, M. Predominance of Dystrophinopathy Genotypes in Mexican Male Patients Presenting as Muscular Dystrophy with A Normal Multiplex Polymerase Chain Reaction DMD Gene Result: A Study Including Targeted Next-Generation Sequencing. Genes 2019, 10, 856. [Google Scholar] [CrossRef] [Green Version]
- Gonzalez-Quereda, L.; Rodriguez, M.J.; Diaz-Manera, J.; Alonso-Perez, J.; Gallardo, E.; Nascimento, A.; Ortez, C.; Natera-de Benito, D.; Olive, M.; Gonzalez-Mera, L.; et al. Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain. Genes 2020, 11, 539. [Google Scholar] [CrossRef] [PubMed]
- Mroczek, M.; Durmus, H.; Topf, A.; Parman, Y.; Straub, V. Four Individuals with a Homozygous Mutation in Exon 1f of the PLEC Gene and Associated Myasthenic Features. Genes 2020, 11, 716. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Solaesa, V.; Serrano-Lorenzo, P.; Ramos-Arroyo, M.A.; Blazquez, A.; Pagola-Lorz, I.; Artigas-Lopez, M.; Arenas, J.; Martin, M.A.; Jerico-Pascual, I. A Novel Missense Variant Associated with A Splicing Defect in A Myopathic Form of PGK1 Deficiency in The Spanish Population. Genes 2019, 10, 785. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pegoraro, V.; Angelini, C. Circulating miR-206 as a Biomarker for Patients Affected by Severe Limb Girdle Muscle Dystrophies. Genes 2021, 12, 85. [Google Scholar] [CrossRef] [PubMed]
- Lim, K.R.Q.; Sheri, N.; Nguyen, Q.; Yokota, T. Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies. Genes 2020, 11, 765. [Google Scholar] [CrossRef] [PubMed]
- Sun, C.; Shen, L.; Zhang, Z.; Xie, X. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update. Genes 2020, 11, 837. [Google Scholar] [CrossRef] [PubMed]
- Lim, K.R.Q.; Nguyen, Q.; Dzierlega, K.; Huang, Y.; Yokota, T. CRISPR-Generated Animal Models of Duchenne Muscular Dystrophy. Genes 2020, 11, 342. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ballester-Lopez, A.; Linares-Pardo, I.; Koehorst, E.; Nunez-Manchon, J.; Pintos-Morell, G.; Coll-Canti, J.; Almendrote, M.; Lucente, G.; Arbex, A.; Magana, J.J.; et al. The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1. Genes 2020, 11, 757. [Google Scholar] [CrossRef] [PubMed]
- Castro, A.F.; Loureiro, J.R.; Bessa, J.; Silveira, I. Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries. Genes 2020, 11, 1418. [Google Scholar] [CrossRef] [PubMed]
- López-Martínez, A.; Soblechero-Martín, P.; de-la-Puente-Ovejero, L.; Nogales-Gadea, G.; Arechavala-Gomeza, V. An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I. Genes 2020, 11, 1109. [Google Scholar] [CrossRef] [PubMed]
- Ballester-Lopez, A.; Koehorst, E.; Linares-Pardo, I.; Nunez-Manchon, J.; Almendrote, M.; Lucente, G.; Arbex, A.; Puente, C.; Lucia, A.; Monckton, D.G.; et al. Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1. Genes 2020, 11, 1321. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Arechavala-Gomeza, V.; Gonzalez-Quereda, L. Special Issue “Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy”. Genes 2021, 12, 242. https://doi.org/10.3390/genes12020242
Arechavala-Gomeza V, Gonzalez-Quereda L. Special Issue “Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy”. Genes. 2021; 12(2):242. https://doi.org/10.3390/genes12020242
Chicago/Turabian StyleArechavala-Gomeza, Virginia, and Lidia Gonzalez-Quereda. 2021. "Special Issue “Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy”" Genes 12, no. 2: 242. https://doi.org/10.3390/genes12020242
APA StyleArechavala-Gomeza, V., & Gonzalez-Quereda, L. (2021). Special Issue “Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy”. Genes, 12(2), 242. https://doi.org/10.3390/genes12020242